The IPO Buzz: Zenas BioPharma (ZBIO) Prices Upsized IPO at $17.00 Mid-Point
Zenas BioPharma (ZBIO) upsized its IPO at pricing to 13.24 million shares (13,235,294 shares) - up from 11.76 million shares in the prospectus - and priced its IPO at $17.00 - the mid-point of its $16.00-to-$18.00 price range - to raise $225.0 million on Thursday night, Sept. 12, 2024. At pricing, Zenas BioPharma increased the IPO's number of shares by 12.55 percent. Zenas BioPharma's stock opened..
Read more September 13, 2024IPO Calendar
Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
---|---|---|---|---|---|---|
Bicara Therapeutics | BCAX | 17.5 | $ 315.0 mil | 9/13/2024 Priced | S/O | S/O |
MBX Biosciences | MBX | 10.2 | $ 163.2 mil | 9/13/2024 Priced | S/O | S/O |
Zenas BioPharma Inc. | ZBIO | 13.2 | $ 225.0 mil | 9/13/2024 Priced | S/O | S/O |
Last 100 IPOs - September 14, 2024
Number of IPOs priced : | 100 |
Number Up: | 49 |
Number Down: | 49 |
Number Unchanged: | 2 |
Percentage Change From Issue Price: | 8.61% |
Percentage Change for The Nasdaq Composite | -100.00% |
2024 IPO Scorecard - September 14, 2024
Number of IPOs priced (Excluding 32 units) : | 115 |
Number Up: | 55 |
Number Down: | 58 |
Number Unchanged: | 2 |
Total Return From Issue Price: | 9.37% |
The Nasdaq Composite Index YTD % Change | -100.00% |